Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 10/1/2025

Chronic Migraine Management in Women

Diagnostic Evaluation

  • The American Academy of Family Physicians recommends evaluating for "red flags" necessitating brain imaging, including sudden onset or "thunderclap" headache, worsening in recumbent position or with Valsalva maneuver, focal neurological deficits, headache waking the patient from sleep or progressively worsening, and significant change in headache pattern 1, 2
  • The American Academy of Family Physicians suggests that if no red flags are identified, imaging is generally not necessary, but the threshold for imaging should be lower in women over 50 years old with recently onset headaches 1, 3

Prophylactic Treatment

  • The American Headache Society recommends topiramate as the first-line prophylactic treatment for chronic migraine, with a dosage of 50-100 mg orally per day 4, 2, 5
  • The American Academy of Neurology suggests that amitriptyline, beta-blockers, and candesartan can be used as alternative prophylactic treatments for chronic migraine 7, 8, 2

Acute Treatment

  • The American Academy of Family Physicians recommends using NSAIDs (ibuprofen, naproxen) for mild to moderate migraine attacks, and triptans for moderate to severe attacks, with caution in women over 50 years old due to increased cardiovascular risk 9, 12

Special Considerations in Women

  • The American College of Obstetricians and Gynecologists recommends that women with migraine should avoid combined hormonal contraceptives if they have migraine with aura, due to increased risk of stroke 7, 8
  • The American Academy of Neurology suggests that valproate should not be used in women of childbearing age due to its teratogenic effects 7, 8

Lifestyle Modifications

  • The American Heart Association recommends identifying and treating modifiable risk factors, such as obesity, caffeine overuse, sleep apnea, and psychiatric comorbidities, to reduce migraine frequency and severity 6, 11

Follow-up and Re-evaluation

  • The American Academy of Neurology recommends evaluating treatment response within 2-3 months after initiation or change of treatment, including frequency of migraine attacks, severity of attacks, and disability related to migraine 7, 8